Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03832946 · ClinicalTrials.gov registry record · Phase 2
A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 2 study, sponsored by Galecto Biotech AB.
- Completed
- Registry status
- Phase 2
- Development phase
- 172
- Enrollment target
NCT03832946: Completed Phase 2 study, sponsored by Galecto Biotech AB.
NCT03832946 is a Phase 2 study that has completed, run by Galecto Biotech AB. The registered enrollment target is 172 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (29% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03832946, a Phase 2 study, has completed, sponsored by Galecto Biotech AB.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 172 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of GB0139.
Primary Outcome
Efficacy of GB0139 as measured by the annual rate of decline in FVC expressed in mL
Interventions
- DRUG Placebo
- DRUG GB0139
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2019-02-19 |
| Est. Completion | 2023-05-17 |
| Phase | Phase 2 |
What the finished NCT03832946 record still lists
NCT03832946 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (29% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03832946 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03832946 about?
NCT03832946 is a clinical study titled "A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)". This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of GB0139.
What is the current status of trial NCT03832946?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 172 participants. The study started on 2019-02-19. Estimated completion is 2023-05-17.
What interventions are being tested in trial NCT03832946?
The interventions under investigation include: Placebo (DRUG), GB0139 (DRUG).
Who is sponsoring clinical trial NCT03832946?
This trial is sponsored by Galecto Biotech AB, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03832946's enrollment target sits among peer trials
172 397th of 2000 higher than 1,603 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI